Source: Program & Abstracts. Conference titles: Annual Meeting of the Endocrine Society's. Unidade: FM
Subjects: PUBERDADE PRECOCE, HIDROXILASE (DEFICIÊNCIA), RESUMOS (CONGRESSOS)
ABNT
GOMES, Larissa G. et al. Normal final height after use of cyproterone acetate in treatment of central precocious puberty secondary to 21-hydroxylase deficiency. 2006, Anais.. Boston: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 07 nov. 2024.APA
Gomes, L. G., Brenlha, E. M. L., Ueti, R. C., Madureira, G., Arnhold, I. J. P., Mendonça, B. B. de, & Bachega, T. A. S. S. (2006). Normal final height after use of cyproterone acetate in treatment of central precocious puberty secondary to 21-hydroxylase deficiency. In Program & Abstracts. Boston: Faculdade de Medicina, Universidade de São Paulo.NLM
Gomes LG, Brenlha EML, Ueti RC, Madureira G, Arnhold IJP, Mendonça BB de, Bachega TASS. Normal final height after use of cyproterone acetate in treatment of central precocious puberty secondary to 21-hydroxylase deficiency. Program & Abstracts. 2006 ;[citado 2024 nov. 07 ]Vancouver
Gomes LG, Brenlha EML, Ueti RC, Madureira G, Arnhold IJP, Mendonça BB de, Bachega TASS. Normal final height after use of cyproterone acetate in treatment of central precocious puberty secondary to 21-hydroxylase deficiency. Program & Abstracts. 2006 ;[citado 2024 nov. 07 ]